157 related articles for article (PubMed ID: 23830988)
1. Generation of an antibody that recognizes Plasmodium chabaudi cysteine protease (chabaupain-1) in both sexual and asexual parasite life cycle and evaluation of chabaupain-1 vaccine potential.
Armada A; Gazarini ML; Gonçalves LM; Antunes S; Custódio A; Rodrigues A; Almeida AJ; Silveira H; Rosário Vd; Santos-Gomes G; Domingos A
Exp Parasitol; 2013 Sep; 135(1):166-74. PubMed ID: 23830988
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium chabaudi: expression of active recombinant chabaupain-1 and localization studies in Anopheles sp.
Caldeira RL; Gonçalves LM; Martins TM; Silveira H; Novo C; Rosário Vd; Domingos A
Exp Parasitol; 2009 Jun; 122(2):97-105. PubMed ID: 19292986
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.
Wiser MF; Giraldo LE; Schmitt-Wrede HP; Wunderlich F
Exp Parasitol; 1997 Jan; 85(1):43-54. PubMed ID: 9024201
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments.
Cavinato RA; Bastos KR; Sardinha LR; Elias RM; Alvarez JM; d'Império Lima MR
Parasite Immunol; 2001 Nov; 23(11):587-97. PubMed ID: 11703810
[TBL] [Abstract][Full Text] [Related]
6. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
[TBL] [Abstract][Full Text] [Related]
7. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
8. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
9. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
Couper KN; Phillips RS; Brombacher F; Alexander J
Parasite Immunol; 2005 May; 27(5):171-80. PubMed ID: 15987340
[TBL] [Abstract][Full Text] [Related]
10. Immunization against a merozoite sheddase promotes multiple invasion of red blood cells and attenuates Plasmodium infection in mice.
Smith RC; Colón-López DD; Bosch J
Malar J; 2014 Aug; 13():313. PubMed ID: 25115675
[TBL] [Abstract][Full Text] [Related]
11. Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.
Kumar A; Kumar K; Korde R; Puri SK; Malhotra P; Singh Chauhan V
Infect Immun; 2007 Apr; 75(4):2026-34. PubMed ID: 17242063
[TBL] [Abstract][Full Text] [Related]
12. Malaria vaccine.
Khurana SK; Talib VH
Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
[TBL] [Abstract][Full Text] [Related]
13. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
14. Falcipains and other cysteine proteases of malaria parasites.
Rosenthal PJ
Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
16. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
Rainczuk A; Scorza T; Smooker PM; Spithill TW
Infect Immun; 2003 Aug; 71(8):4506-15. PubMed ID: 12874330
[TBL] [Abstract][Full Text] [Related]
17. Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge.
Lord R; Jones GL; Spencer L; Saul A
Parasite Immunol; 1993 Nov; 15(11):613-8. PubMed ID: 7533280
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles.
Dutta S; DasSarma P; DasSarma S; Jarori GK
Malar J; 2015 Oct; 14():406. PubMed ID: 26463341
[TBL] [Abstract][Full Text] [Related]
19. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.
Anders RF; Crewther PE; Edwards S; Margetts M; Matthew ML; Pollock B; Pye D
Vaccine; 1998; 16(2-3):240-7. PubMed ID: 9607037
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
